about
Ximelagatran: a new type of oral anticoagulant.Oral heparin: status reviewGenetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.Ximelagatran: a new antithrombotic option in atrial fibrillation.Ximelagatran for stroke prevention in atrial fibrillation.Secondary prevention of cardioembolic stroke: oldest and newest promises.
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Warfarin for atrial fibrillation: the end of an era?
@ast
Warfarin for atrial fibrillation: the end of an era?
@en
Warfarin for atrial fibrillation: the end of an era?
@nl
type
label
Warfarin for atrial fibrillation: the end of an era?
@ast
Warfarin for atrial fibrillation: the end of an era?
@en
Warfarin for atrial fibrillation: the end of an era?
@nl
prefLabel
Warfarin for atrial fibrillation: the end of an era?
@ast
Warfarin for atrial fibrillation: the end of an era?
@en
Warfarin for atrial fibrillation: the end of an era?
@nl
P1433
P1476
Warfarin for atrial fibrillation: the end of an era?
@en
P2093
Brian R Chambers
Helen M Dewey
P356
10.1016/S1474-4422(04)00738-0
P407
P577
2004-05-01T00:00:00Z